| 产品名称: | NCI-H1238 H1238 |
|---|---|
| 商品货号: | TS211358 |
| Organism: | Homo sapiens, human |
| Product Format: | frozen |
| Culture Properties: | suspension; some adherent cells |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease: | stage E, carcinoma; small cell lung cancer (SCLC) |
| Age: | 64 years |
| Gender: | male |
| Ethnicity: | White |
| Derivation: | The line was established in November 1985. |
| Clinical Data: | The patient was a smoker. male White 64 years |
| Comments: | The line was established in November 1985. The patient was a smoker. 130 pack years. |
| Complete Growth Medium: | HITES medium supplemented with 5% fetal bovine serum
|
| Subculturing: | Medium Renewal: Add fresh medium every 3 to 4 days (depending on cell density) Cultures can be maintained by addition of fresh medium. Cells grow as floating aggregates of round cell clusters. Some cells will attach. |
| Cryopreservation: | Culture medium with an additional 45% fetal bovine serum, 95%; DMSO, 5% |
| Culture Conditions: | Temperature: 37°C |
| STR Profile: | Amelogenin: X,Y CSF1PO: 11 D13S317: 8,14 D16S539: 10 D5S818: 13 D7S820: 11 THO1: 9,9.3 TPOX: 8 vWA: 18,19 |
| Name of Depositor: | AF Gazdar, JD Minna |
| Deposited As: | Homo sapiens |
| Year of Origin: | 1985 |
| References: | NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. |